- Global Pharma News & Resources

Press Releases - 2019-09-28

Date Title Company
28-Sep-2019 New Data Demonstrate Strong Outcomes for Abbott Device to Repair Leaky Tricuspid Heart Valves Abbott
28-Sep-2019 ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress ESSA Pharma Inc
28-Sep-2019 Heart Health Supplements Market Amazing Growth By 2028 – NutriGold, Glanbia PLC, Bayer AG Wired Release
28-Sep-2019 Airway Management Device Market Analysis, Business Strategies, Segmentation and Forecasts 2019-2028 Wired Release
28-Sep-2019 Find Out How Biotech Flavour Market Is Developing Globally In The Forseen Years 2019-2028? Wired Release
28-Sep-2019 2019 Dermal Fillers Market | Top Leading Regions, Top Manufacturers – Allergan, Sinclair Pharma, Bioha Laboratories Wired Release
28-Sep-2019 Tolero Pharmaceuticals Presents Preliminary Findings from Phase 1 Study Evaluating Investigational Agent TP-0903 in Patients with Advanced Solid Tumors at ESMO 2019 Tolero Pharmaceuticals, Inc.
28-Sep-2019 BERG Presents First-In-Kind Data Using Its Bayesian AI-Driven Interrogative Biology® Technology To Map Underlying Biology Of Patient Responses In Advanced Solid Tumor Trial Of BPM31510 BERG
28-Sep-2019 Bayer Announces Updated Analysis for Vitrakvi® (larotrectinib) Demonstrating High Response Rate and Duration of Response of Nearly Three Years in Adults and Children with TRK Fusion Cancer Bayer
28-Sep-2019 GSK presents new data showing promising anti-tumour activity with GSK3359609, an ICOS receptor agonist, in combination with pembrolizumab in head and neck squamous cell carcinoma (HNSCC) GlaxoSmithKline plc
28-Sep-2019 Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer Astellas
28-Sep-2019 Cellular Biomedicine Group's ReJoin® Therapy Receives Stem Cell Drug Application Acceptance For Phase II Clinical Trials by China NMPA Cellular Biomedicine Group
28-Sep-2019 RH Nanopharmacuticals, LLC  Receives NIH HEAL Grant To Develop And Test Intravenous Micronized Salsalate As A Safer Alternative To Opioids  For Acute Post Operative Pain Management RH Nanopharmaceuticals